Recap: Jazz Pharmaceuticals Q1 Earnings - Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals JAZZ reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Jazz Pharmaceuticals missed estimated earnings by 6.84%, reporting an EPS of $3.95 versus an estimate of $4.24.

Revenue was up $79.09 million from the same period last year.

Last quarter the company missed on EPS by $0.39 which was followed by a 2.73% increase in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.32	4.66	4.2	3.83
EPS Actual	-0.07	5.17	4.3	3.73
Revenue Estimate	975.59M	939.06M	904.21M	853.52M
Revenue Actual	972.12M	940.65M	932.88M	813.72M

To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.